Fulcrum Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Fulcrum Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2018 to Q2 2024.
  • Fulcrum Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $1.99M, a 0.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.99M -$6K -0.3% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $1.99M -$43K -2.12% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $2.01M -$94K -4.47% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $1.99M -$108K -5.15% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2M -$111K -5.27% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.03M +$1.22M +149% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.11M +$1.56M +288% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $2.1M +$1.58M +304% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.11M +$1.58M +297% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $816K +$253K +44.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $542K -$36K -6.23% Dec 31, 2021 10-K/A 2023-06-26
Q3 2021 $519K -$97K -15.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $531K +$455K +599% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $563K +$484K +613% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $578K +$519K +880% Dec 31, 2020 10-K/A 2023-06-26
Q3 2020 $616K +$557K +944% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $76K -$548K -87.8% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $79K Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $59K +$21K +55.3% Dec 31, 2019 10-K/A 2023-06-23
Q3 2019 $59K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $624K Jun 30, 2019 10-Q 2019-08-26
Q4 2018 $38K Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.